An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed signs of anti-tumor activity, including an unconfirmed partial ...

REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule MEK 1/2 inhibitor. The platform analyzed cellular models of APC gene loss—the root cause of FAP—to identify compounds ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

What are the key benefits of participating in a clinical trial for GI cancer, and how does your expertise in conducting all phases of trials ensure patient safety and access to cutting-edge treatments ...

Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...

We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.” The ...

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

Researchers hope to launch human clinical ... trial," Bhaskar said, adding that he and his colleagues are seeking funding from venture capitalists and the Alzheimer's Association to launch a Phase ...